Inventor · disambiguated record
A. K. Gunnar Aberg
Also filed as: ABERG A K GUNNAR
41 granted patents·581 citations·filing 1994–2014
98Inventor score
Top patents by PatentIndex Score
41 records- 0193US8557846B1Medicinal treatment of dermal diseases in dogsBRIDGE PHARMA INC·Filed 2013·Granted Oct 15, 2013·17 cites·16 claims
- 0291US7557128B2Optically active isomers of ketotifen and therapeutically active metabolites thereofBRIDGE PHARMA INC·Filed 2007·Granted Jul 7, 2009·21 cites·12 claims
- 0391US6313144B1Compositions of optically pure (−) norcisaprideSEPRACOR INC·Filed 2000·Granted Nov 6, 2001·25 cites·10 claims
- 0490US7226934B1Optically active isomers of ketotifen and therapeutically active metabolites thereofBRIDGE PHARMA INC·Filed 2000·Granted Jun 5, 2007·41 cites·13 claims
- 0590US5595997AMethods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadineSEPRACOR INC·Filed 1994·Granted Jan 21, 1997·82 cites·7 claims
- 0689US7723392B2Use of RR/SR-ractopamineBRIDGE PHARMA INC·Filed 2008·Granted May 25, 2010·18 cites·22 claims
- 0787US8969385B2Ocular formulations of norketotifenBRIDGE PHARMA INC·Filed 2014·Granted Mar 3, 2015·4 cites·14 claims
- 0887US6384054B1Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredientsSEPRACOR INC·Filed 2001·Granted May 7, 2002·17 cites·38 claims
- 0986US7985775B2Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animalsBRIDGE PHARMA INC·Filed 2007·Granted Jul 26, 2011·6 cites·21 claims
- 1084US6207684B1Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic useBRIDGE PHARMA INC·Filed 1998·Granted Mar 27, 2001·72 cites·7 claims
- 1183US6432446B2Non-arrhythmogenic metabolite of oxybutyninBRIDGE PHARMA INC·Filed 2001·Granted Aug 13, 2002·20 cites·7 claims
- 1283US6303632B1Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredientsSEPRACOR INC·Filed 2001·Granted Oct 16, 2001·11 cites·10 claims
- 1382US8741930B2Treating xerophthalmia with norketotifenABERG A K GUNNAR·Filed 2008·Granted Jun 3, 2014·2 cites·18 claims
- 1482US6413987B1Dermal anesthetic agentsBRIDGE PHARMA INC·Filed 2000·Granted Jul 2, 2002·20 cites·18 claims
- 1579US6187795B1Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredientsSEPRACOR INC·Filed 2000·Granted Feb 13, 2001·8 cites·4 claims
- 1675US7214684B2Methods for the treatment of allergic rhinitisSEPRACOR INC·Filed 2004·Granted May 8, 2007·4 cites·2 claims
- 1775US6123961ATreating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutyninBRIDGE PHARMA INC·Filed 1997·Granted Sep 26, 2000·44 cites·12 claims
- 1874US6458809B1Methods for treating disorders using norastemizole in combination with other active ingredientsSEPRACOR INC·Filed 2002·Granted Oct 1, 2002·3 cites·28 claims
- 1974US5731319AMethods for treating disorders using descarboethoxyloratadineSEPRACOR INC·Filed 1997·Granted Mar 24, 1998·31 cites·7 claims
- 2068US7141696B2Smooth muscle spasmolytic agentsBRIDGE PHARMA INC·Filed 2004·Granted Nov 28, 2006·4 cites·17 claims
- 2168US6130233AMethods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizoleSEPRACOR INC·Filed 1994·Granted Oct 10, 2000·14 cites·4 claims
- 2268US5877189AMethods for treating central nervous system disorders and other disorders using optically pure (-) norcisaprideSEPRACOR INC·Filed 1997·Granted Mar 2, 1999·17 cites·4 claims
- 2367US6110974AMethods of accelerating muscle growth and improving feed efficiency in animals by using optically pure eutomers of adrenergic beta-2 receptor agonists, and food supplements containing the sameBRIDGE PHARMA INC·Filed 1998·Granted Aug 29, 2000·31 cites·6 claims
- 2466US8071653B2Use of RR/SR-ractopamineABERG A K GUNNAR·Filed 2010·Granted Dec 6, 2011·1 cites·12 claims
- 2565US7872025B2Optically active isomers of ketotifen and therapeutically active metabolites thereofBRIDGE PHARMA INC·Filed 2009·Granted Jan 18, 2011·0 cites·13 claims
- 2665US6337339B2Methods and compositions for treating infection using optically pure (S)-lomefloxacinSEPRACOR INC·Filed 2001·Granted Jan 8, 2002·1 cites·14 claims
- 2764US6207683B1Benzocycloheptathiophene compoundsBRIDGE PHARMA INC·Filed 1998·Granted Mar 27, 2001·21 cites·20 claims
- 2861US8445542B2Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animalsBRIDGE PHARMA INC·Filed 2012·Granted May 21, 2013·0 cites·19 claims
- 2959US6534508B2Methods and compositions for treating infection using optically pure (S)-lomefloxacinSEPRACOR INC·Filed 2001·Granted Mar 18, 2003·0 cites·14 claims
- 3056US6124320AMethods for treating allergic disorders using norastemizoleSEPRACOR INC·Filed 1996·Granted Sep 26, 2000·8 cites·15 claims
- 3155US8383685B2Use of RR/SR-ractopamineBRIDGE PHARMA INC·Filed 2011·Granted Feb 26, 2013·0 cites·3 claims
- 3252US6268382B1Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredientsSEPRACOR INC·Filed 2000·Granted Jul 31, 2001·0 cites·8 claims
- 3352US6207852B1Smooth muscle spasmolytic agents, compositions and methods of use thereofBRIDGE PHARMA INC·Filed 1997·Granted Mar 27, 2001·11 cites·26 claims
- 3452US6187794B1Methods for treating allergic disorders and other disorders using norastemizoleSEPRACOR INC·Filed 2000·Granted Feb 13, 2001·0 cites·12 claims
- 3549US6372799B1Non-sedating diphenhydramine metabolitesBRIDGE PHARMA INC·Filed 1999·Granted Apr 16, 2002·11 cites·18 claims
- 3645US7592458B2Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic painWRIGHT GEORGE E·Filed 2007·Granted Sep 22, 2009·0 cites·14 claims
- 3740US7211582B1Methods for treating urticaria using descarboethoxyloratadineSEPRACOR INC·Filed 1999·Granted May 1, 2007·4 cites·2 claims
- 3840US6274595B1Compositions for treating infection using optically pure (S)-lomefloxacinSEPRACOR INC·Filed 1999·Granted Aug 14, 2001·3 cites·11 claims
- 3940US6075024AMethods for treating infection using optically pure (S)-lomefloxacinSEPRACOR INC·Filed 1995·Granted Jun 13, 2000·3 cites·10 claims
- 4038US7214683B1Compositions of descarboethoxyloratadineSEPRACOR INC·Filed 1998·Granted May 8, 2007·4 cites·12 claims
- 4138US6156770ACompositions of optically pure (-) norcisapride and another therapeutic agentSEPRACOR INC·Filed 1998·Granted Dec 5, 2000·2 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when A. K. Gunnar Aberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →